title: [Pharmacokinetics of pirarubicin (THP-doxorubicin) in patients with cancer].
authors.affiliation: Fondation Bergonié, Bordeaux, France.
authors.forename: J
authors.initials: J
authors.lastname: Robert
authors.forename: M
authors.initials: M
authors.lastname: David
authors.forename: S
authors.initials: S
authors.lastname: Huet
authors.forename: J
authors.initials: J
authors.lastname: Chauvergne
authors.forename: A
authors.initials: A
authors.lastname: Monnier
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use / Q000652:urine; D005260:Female; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D004317:Doxorubicin; C027260:pirarubicin
vernacular_title: Pharmacocinétique de la pirarubicine (THP-doxorubicine) chez des malades cancéreux.